Inactief instrument

Andere talen Viralytics Ltd.

Aandelen

VLA

AU000000VLA6

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Amgen : Merck to buy virus-based cancer drug firm Viralytics for $394 million	21-02-18
Immunothérapie: Merck & Co achète l'australien Viralytics	21-02-18
Viralytics : Chairman’s letter to shareholders	28-11-17
Viralytics : New Data Presented at SITC Annual Meeting	12-11-17
Viralytics : Annual Report and Full Year Financial Results	18-08-17
Viralytics : Newsletter	28-06-17
Viralytics : Positive Bio-Marker Data from CANON Study	28-06-17
Viralytics : Update on MITCI and KEYNOTE 200 trials at ASCO Ann Meeting	06-06-17
Viralytics : Progress in the CAVATAK® and KEYTRUDA® Combination KEYNOTE-200 clinical trial	05-04-17
Viralytics : CAVATAK® in Combination with YERVOY® Provides Promising Results in Advanced Melanoma from the Phase 1b MITCI clinical study	05-04-17
Viralytics : Promising Results in CAPRA Trial of CAVATAK® in Combination with KEYTRUDA® in Melanoma Patients	04-04-17
Viralytics : Edison Report – Cavatak combo data at AACR next month	09-03-17
Viralytics : ASX Release – Viralytics to Present New CAVATAK Clinical Data at American Association for Cancer Research Annual Meeting 2017	02-03-17
Viralytics : Receives $4.3 Million R&D Tax Incentive	16-02-17
Viralytics : Promising Advanced Melanoma Results from KEYTRUDA Combination Trial announced at SITC	14-11-16
Viralytics : Dr Malcolm McColl on ABC TV's The Business	06-06-16
Edison: Eye-catching MITCI Data	10-05-16
Viralytics : Further Promising Data at AACR Meeting	21-04-16
Viralytics : Clinical Results at Two Major Conferences	17-03-16
Viralytics : Bioshares Top Six Stock Picks for 2016	21-12-15

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Viralytics Ltd.

Aandelen

VLA

AU000000VLA6

Andere talen

Filters